Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...

People with asthma, chronic obstructive pulmonary disease (COPD), and certain other respiratory conditions typically receive Medicare coverage for inhalers. To receive coverage, a person must have ...

Background: The proliferation of inhaler devices has resulted in a ... When selecting an aerosol delivery device for patients with asthma and COPD, the following should be considered: device ...

Who shouldn't use inhaled insulin? People with asthma or chronic obstructive pulmonary disease (COPD) should avoid inhaled insulin. It can raise your chances of tightening of the muscles that line ...

New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition ... to-high doses of inhaled ...